Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Circulating Tumour DNA Marker for Pre-neoplastic Colorectal Tumours.

NCT07776548 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT07776548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07776548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Circulating Tumour DNA Marker for Pre-neoplastic Colorectal Tumours.
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 4, 2027
Completion date
January 3, 2029
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colorectal laterally spreading tumours (lsts)